Hikma Pharmaceutical | Fremdkapital



Loan Capital Veränderung Datum
Almirall EUR 351.76M 538K 2024-06
AstraZeneca USD 27.89B 154M 2025-03
Autolus Therapeutics Ltd 244.6M 219.71M 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Fresenius EUR 13.28B 1.81B 2024-12
Galapagos EUR 7.79M 453K 2025-03
Genmab DKK 937M 41M 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
GRIFOLS EUR 8.68B 155.99M 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Lonza CHF 4.24B 602M 2024-12
Merck EUR 6.37B 1.51B 2024-12
Orion EUR 290.8M 6.4M 2025-03
Recordati EUR 1.26B 87.43M 2024-09
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
UCB EUR 2.82B 166M 2024-12



Hikma Pharmaceutical Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.